Bamco Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $4,558 - $6,277	174 Added 0.11%	156,619 $4.21 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $632,195 - $1.04 Million	25,127 Added 19.13%	156,445 $5.58 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $659,653 - $1.07 Million	-27,857 Reduced 17.5%	131,318 $3.34 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $5.03 Million - $7.29 Million	-179,617 Reduced 53.02%	159,175 $6.46 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $4,444 - $7,246	-150 Reduced 0.04%	338,792 $11.2 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $15.3 Million - $28 Million	-552,299 Reduced 61.97%	338,942 $11.9 Million
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $3.97 Million - $7.01 Million	-100,152 Reduced 10.1%	891,241 $41 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $941,116 - $1.34 Million	-16,201 Reduced 1.61%	991,393 $65.7 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $325,702 - $473,991	-5,579 Reduced 0.55%	1,007,594 $62.9 Million
Q2 2021 Aug 13, 2021	BUY	$62.15 - $90.32 $5.52 Million - $8.02 Million	88,743 Added 9.6%	1,013,173 $83.9 Million
Q1 2021 May 19, 2021	BUY	$61.35 - $90.47 $15.9 Million - $23.5 Million	259,793 Added 39.09%	924,430 $61.3 Million
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $12.8 Million - $25 Million	293,216 Added 78.94%	664,637 $51 Million
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $3.68 Million - $5.68 Million	110,712 Added 42.47%	371,421 $16 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $3.93 Million - $6.51 Million	150,459 Added 136.47%	260,709 $11.3 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $650,847 - $2 Million	31,656 Added 40.28%	110,250 $3.17 Million
Q4 2019 Feb 18, 2020	SELL	$28.14 - $73.01 $2.47 Million - $6.4 Million	-87,700 Reduced 52.74%	78,594 $4.99 Million
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $13,130 - $17,430	500 Added 0.3%	166,294 $4.69 Million
Q2 2019 Aug 15, 2019	SELL	$17.43 - $28.82 $29,631 - $48,994	-1,700 Reduced 1.01%	165,794 $4.39 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $7,796 - $13,056	647 Added 0.39%	167,494 $3.07 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $1.79 Million - $3.29 Million	166,847 New	166,847 $2.07 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account